HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges
Jul 1, 2025, 00:00
10.1016/j.jval.2025.04.987
https://www.valueinhealthjournal.com/article/S1098-3015(25)01112-X/fulltext
Title :
HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)01112-X&doi=10.1016/j.jval.2025.04.987
First page :
Section Title :
Open access? :
No
Section Order :
10694